Pramod Gupta - Net Worth and Insider Trading

Pramod Gupta Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pramod Gupta owns 1 companies in total, including Unicycive Therapeutics Inc (UNCY) .

Click here to see the complete history of Pramod Gupta’s form 4 insider trades.

Insider Ownership Summary of Pramod Gupta

Ticker Comapny Transaction Date Type of Owner
UNCY Unicycive Therapeutics Inc 2021-07-15 EVP & Pharmaceuticals and BD

Pramod Gupta Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Pramod Gupta Ownership Network

Ownership Network List of Pramod Gupta

No Data

Ownership Network Relation of Pramod Gupta

Insider Network Chart

Pramod Gupta Owned Company Details

What does Unicycive Therapeutics Inc do?

Who are the key executives at Unicycive Therapeutics Inc?

Pramod Gupta is the EVP & Pharmaceuticals and BD of Unicycive Therapeutics Inc. Other key executives at Unicycive Therapeutics Inc include other: EVP of Corporate Strategy Douglas Jermasek , Chief Financial Officer John Townsend , and director & CEO Shalabh K. Gupta .

Unicycive Therapeutics Inc (UNCY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Unicycive Therapeutics Inc (UNCY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Unicycive Therapeutics Inc (UNCY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Unicycive Therapeutics Inc (UNCY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Unicycive Therapeutics Inc Insider Transactions

No Available Data

Pramod Gupta Mailing Address

Above is the net worth, insider trading, and ownership report for Pramod Gupta. You might contact Pramod Gupta via mailing address: Unicycive Therapeutics, Inc., 5150 El Camino Real, Suite A-32, Los Altos Ca 94022.

Discussions on Pramod Gupta

No discussions yet.